Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
46 /100
MEDIUM RISK
Score updated Oct 13, 2026

PRQR — ProQR Therapeutics N.V. Dilution Risk Tracker

Track PRQR dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track PRQR — Get alerts when the score changes →

As of October 13, 2026, ProQR Therapeutics N.V. (PRQR) has a DilutionWatch DilutionScore of 46/100, rated MEDIUM dilution risk. ProQR Therapeutics N.V. has a market capitalization of $171.74M, 105.36M shares outstanding, 70 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
42
💰 Cash Runway
40
📊 Float Risk
20
⚠️ Warrant Exposure
40
🔄 Convertible Debt
40

Dilution Forecast

⛅
Watch
Minor dilution signals detected
model est. 15%
🔄 Reverse Split model est. 30%
• 50-day avg $1.64 approaching $1 threshold
🔔 Track PRQR — Get forecast alerts →

Market Data

Market Cap$171.74M
Shares Outstanding105.36M
Float64.35M
Cash$94.54M
Debt$18.34M
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore46/100DilutionWatch score record
Shares Outstanding105.36MVerified float table or market cache
Public Float64.35MVerified float table or market cache
Market Cap$171.74MMarket data cache
Cash RunwayNot availableDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding WarrantsNone in current score inputsSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 0.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↑ 7.0% shares (2026Q1 vs prior)
70 institutional holders · 39.98M shares
#1 ADAGE CAPITAL PARTNERS GP, L.L.C. 6.25M shares
#2 MORGAN STANLEY 5.57M shares
#3 Privium Fund Management B.V. 5.47M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest2.87M
Days to Cover5.0
% of Float4.5%
FINRA data as of Sep 30, 2026

Recent SEC Activity

No recent SEC insights

Recent News

No recent news available for this ticker.

DilutionScore History — Last 90 Days

PRQR's DilutionScore is currently 46/100 (Medium risk), with 1 score change tracked over 89 days. The score improved from 45/100 (Medium risk).

Period Score Risk Level Duration
Aug 14 – Oct 13, 202646/100MEDIUM60 days
Jul 16 – Aug 13, 202645/100MEDIUM29 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

PRQR shares outstanding have increased 0.0% from 105.35M (Mar 2026) to 105.36M (Apr 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
Apr 21, 2026105.36M64.35M▲ 0.43%
Mar 22, 2026105.35M64.07M▼ 0.48%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track PRQR Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment PRQR files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking PRQR — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for PRQR
PRQR FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.